Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur Weinstein

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Journal of Cataract and Refractive Surgery|July 2, 2013
July consultation #4Arthur Weinstein
Arthritis & Rheumatology (Hoboken, N.J.)|February 19, 2020
Cell-Bound Complement Activation Products Are Superior to Serum Complement C3 and C4 Levels to Detect Complement Activation in Systemic Lupus Erythematosus: Comment on the Article by Aringer et alArthur Weinstein
Rheumatic Diseases Clinics of North America|November 16, 2023
Naomi Rothfield, MD, MACR: A Giant Gift in a Small PackageArthur Weinstein
Journal of Cataract and Refractive Surgery|February 21, 2012
Surgical experience with pseudophakic negative dysphotopsiaArthur Weinstein
The Journal of Rheumatology|September 25, 2013
Dr. Weinstein repliesArthur Weinstein
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 6, 2008
Editorial commentary: laboratory testing for Lyme disease: time for a change?Arthur Weinstein
The New England Journal of Medicine|April 27, 2012
IgG4-related diseaseArthur Weinstein
Current Opinion in Rheumatology|July 16, 2002
Lyme arthritis and post-Lyme disease syndromeArthur Weinstein, Michael Britchkov
Arthritis Care & Research|September 25, 2020
A Combination of Complement Activation Products With Autoantibodies Predicts Transition of Probable Lupus to Systemic Lupus Erythematosus: Comment on the Article by Lambers et alRoberta Vezza Alexander, Arthur Weinstein
Current Rheumatology Reports|March 30, 2006
Management of the antiphospholipid syndromePaul DeMarco, Inderprit Singh, Arthur Weinstein
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Journal of Cataract and Refractive Surgery|July 2, 2013
July consultation #4Arthur Weinstein
Arthritis & Rheumatology (Hoboken, N.J.)|February 19, 2020
Cell-Bound Complement Activation Products Are Superior to Serum Complement C3 and C4 Levels to Detect Complement Activation in Systemic Lupus Erythematosus: Comment on the Article by Aringer et alArthur Weinstein
Rheumatic Diseases Clinics of North America|November 16, 2023
Naomi Rothfield, MD, MACR: A Giant Gift in a Small PackageArthur Weinstein
Journal of Cataract and Refractive Surgery|February 21, 2012
Surgical experience with pseudophakic negative dysphotopsiaArthur Weinstein
The Journal of Rheumatology|September 25, 2013
Dr. Weinstein repliesArthur Weinstein
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 6, 2008
Editorial commentary: laboratory testing for Lyme disease: time for a change?Arthur Weinstein
The New England Journal of Medicine|April 27, 2012
IgG4-related diseaseArthur Weinstein
Current Opinion in Rheumatology|July 16, 2002
Lyme arthritis and post-Lyme disease syndromeArthur Weinstein, Michael Britchkov
Arthritis Care & Research|September 25, 2020
A Combination of Complement Activation Products With Autoantibodies Predicts Transition of Probable Lupus to Systemic Lupus Erythematosus: Comment on the Article by Lambers et alRoberta Vezza Alexander, Arthur Weinstein
Current Rheumatology Reports|March 30, 2006
Management of the antiphospholipid syndromePaul DeMarco, Inderprit Singh, Arthur Weinstein
Pageof 5